AL Notes: Morales, Rodriguez, Gonzalez, Duensing
Blue Jays left-hander Franklin Morales is just eight days from accumulating 45 days on the club’s roster, at which point the entirety of his $2MM salary becomes guaranteed, tweets Sportsnet’s Ben Nicholson-Smith. (Morales’ contract contains a 45-day advance consent clause — a common provision which MLBTR’s Zach Links explored at length in Spring Training 2014.) However, Morales is currently on the disabled list and has yet to begin a rehab assignment, meaning there’s virtually no way he’ll be activated by that time. While the Blue Jays could’ve cut loose a healthy Morales within a 45-day window and not had to pay his entire salary, advance consent clauses also prohibit teams from terminating the salary of injured players. As such, Morales is effectively guaranteed to receive all of that $2MM sum. Of course, if Morales pitches as well as he did with the Royals in 2015 upon activation from the DL, the Jays won’t mind that salary.
A few more notes from the American League…
- Eduardo Rodriguez needs to make “at minimum” one more rehab start in the minor leagues, Red Sox manager John Farrell tells Jason Mastrodonato of the Boston Herald. As such, Rodriguez will not be activated from the disabled list this week and is likely to stay with Triple-A Pawtucket for the time being. Rodriguez is OK with the decision, Mastrodonato writes, as his velocity has been topping out at just 93 mph after reaching as high as 98 mph. The Sox have had Rodriguez go through strength testing, and Farrell says that the lefty is still building arm strength, though Rodriguez himself tells WEEI’s Rob Bradford that he made some strides in tonight’s bullpen session. “I could push more with my back leg, and it felt pretty good,” he says. “That’s what I needed to work on, using my lower half. So that’s what I tried to do today in the bullpen, and it went well.”
- The White Sox will go with right-hander Miguel Gonzalez in the recently vacated fifth spot of the rotation, GM Rick Hahn and skipper Robin Ventura told the media (including MLB.com’s Dave Sessions). “With Miguel’s performance both in Charlotte and what he did yesterday, he’s going to get a few opportunities here, probably in a row,” said Hahn. “Quite frankly, we’ve asked a lot of Miguel, bringing him up for a spot start against a really good hitting team in Toronto, and then 10 or 12 days later bringing him back against another difficult offensive team in their home park [on Monday]. I think he showed himself well both times, so he’s earned the right to get a little bit of stability and a little bit of repetition in that spot.
- Royals left-hander Brian Duensing, currently pitching for the club’s Triple-A affiliate, has a May 15 opt-out date approaching, MLB.com’s Jeffrey Flanagan tweeted recently. The longtime Twins lefty is off to a strong start in the minors this season, having worked to a 2.04 ERA with a 15-to-4 K/BB ratio in 17 2/3 innings for the Storm Chasers. The 15 strikeouts, in particular, are encouraging for Duensing, who saw his strikeout rate deteriorate rapidly over the life of his final three seasons in Minnesota.
Minor MLB Transactions: 5/10/16
Here are today’s minor moves from around the game…
- Left-handed reliever Sam Freeman has accepted an outright assignment to Triple-A from the Brewers, the team announced today (on Twitter). Freeman, 28, tossed 7 2/3 innings for Milwaukee earlier this season but yielded an alarming 11 runs on 13 hits and nine walks in that time. He delivered solid bottom-line results for the Rangers last year, logging a 3.05 ERA in 38 1/3 innings, though metrics such as FIP, xFIP and SIERA each indicated that ERA to be largely smoke and mirrors, chiefly because of his trouble consistently throwing strikes. Freeman has averaged 5.3 walks per nine innings pitched in the Majors but a more palatable 3.6 per nine at the Triple-A level, and he’ll look to get back to that level following his outright. Of course, he’ll be doing so in a dreadful environment for pitchers: Colorado Springs.
Nationals Extend Stephen Strasburg
7:00pm: Yahoo’s Jeff Passan reports that Strasburg’s contract does include limited no-trade protection (Twitter link). Passan also adds some context to the deferrals (links to Twitter), reporting that Strasburg’s 2023 salary is a staggering $45MM, but as Svrluga reported, he’ll receive just $15MM in that year, with the rest being deferred. The present-day value of the deal, when factoring in the $70MM worth of deferrals, is a bit north of $160MM, per Passan.
9:19am: In a move that has drastically altered next winter’s free-agent market, the Nationals have officially agreed to a seven-year extension with righty Stephen Strasburg. He’ll reportedly earn a guaranteed $175MM over that term, though the deal does come with some wrinkles.
First and foremost, Strasburg will take home only $15MM annually over the seven seasons of the contract (2017-2023), Barry Svrluga of the Washington Post reports. The remaining $70MM will be deferred without interest and paid out in $10MM installments over 2024 through 2030. That payout structure obviously reduces the present value of the contract: per Svrluga, the club estimates that the deal would be for something like $162MM if those annual salaries were paid in full each year during the seven-year term.
The deal also affords Strasburg opportunities to opt out after its third and fourth seasons. (He’d keep the $25MM annually for the first three or four years, with the deferred amounts moved up.) Strasburg can also tack on $1MM annually for every season in which he reaches 180 innings. So far as has been reported, Strasburg won’t receive no-trade protection and there are no provisions relating to arm health.
Strasburg had been set to reach the open market after the year, and there had been no hint that a deal was in the works. The Scott Boras client currently sits atop the 2016-17 Free Agent Power Rankings of MLBTR’s Tim Dierkes, and had every hope of matching or exceeding the $200MM+ contracts landed by aces Max Scherzer and David Price over the last two winters.
There are some major limiting factors in Strasburg’s case, of course, including his prior Tommy John surgery and injury-limited 2015 campaign. While the Nationals are known for their successful rolls of the dice on pitchers with questionable elbows, the long-term durability of Strasburg’s replacement UCL remains an open question. Additionally, despite generally excellent results, he’s never quite been as dominant as his peripherals would suggest and he’s only topped 200 innings in a season once.
Still, there’s plenty of reason to think that clubs would have lined up for a chance to add Strasburg this winter. He’s pitching in his age-27 season at present, meaning he is selling several younger campaigns than were pitchers like Scherzer and Price. And apart from a bit of a blip last year, Strasburg has been one of the game’s most effective starting pitchers.
In the aggregate, Strasburg has given the Nationals 818 2/3 innings of 3.06 ERA pitching in his seven years of major league action, with a sterling 10.4 K/9 against 2.2 BB/9. But ERA estimators are in accord in suggesting that he’s been even better, as Strasburg carries a 2.78 FIP, 2.72 xFIP, and 2.77 SIERA for his career.
Strasburg has a deep and varied arsenal, beginning with a pair of mid-90s fastballs. Though he’s now sitting just under 95 mph with the heater, well below his early-career numbers, Strasburg has never been wholly reliant on upper-tier velocity. He’s increasingly utilized a slider this season, joining with his already-stellar curve and change to give him five legitimate offerings.
Both sides clearly have their reasons for agreeing to terms, though it remains an unexpected strike given the righty’s combination of age, performance, and short time left to reach the market. Strasburg won’t need to worry about another injury or performance decline interceding before reaching free agency, and he’s clearly comfortable in D.C., which made him the first overall draft selection back in 2009. And for the Nationals, acting now not only represents a chance for a nice discount — particularly once the deferrals are accounted for — but prevents the need to bid for Strasburg’s services against other organizations in a market that is largely devoid of pitching talent.
It’s worth noting that the Nationals are intimately familiar with Strasburg’s health and work ethic, particularly after going through the infamous shutdown of 2012. Having helped spurred the surprising Nats to the front of the NL East, Strasburg was shelved for the end of the regular season and the postseason because he reached pre-determined limits in his first year back from Tommy John surgery.
That episode led to plenty of criticism of GM Mike Rizzo, but Strasburg has not had any elbow issues since. And it seems that the good will has paid off with this deal. It’s fair to note, too, that other pitchers who were handled differently (e.g. Kris Medlen) experienced renewed arm problems, though elbow health remains a murky and complicated subject.
Strasburg is now set to stay with Scherzer atop the Nats staff through at least 2019, when he’ll first have a chance to opt out in advance of his age-31 campaign. It’s fair to say that the rotation looks to be in solid shape for some time to come, as the organization also controls its other current starters for multiple seasons: Gio Gonzalez (through 2018), Tanner Roark (2019), and Joe Ross (2021). And that’s before considering top prospect Lucas Giolito, who has yet to crack the majors.
Chelsea Janes of the Washington Post reported the agreement on Twitter. Jon Heyman of MLB Network reported the length and guarantee, as well as the inclusion of opt-outs, deferrals, and a $1MM annual incentive package (links to Twitter: 1; 2; 3; 4; 5). Ken Rosenthal of FOX Sports tweeted details on the opt-out, as did Barry Svrluga of the Washington Post, while Joel Sherman of the New York Post tweeted details of the incentives.
Photo courtesy of USA Today Sports Images.
Injury Notes: Young, Peralta, Canha, Hendriks
Royals right-hander Chris Young is leaving the team to travel back to Kansas City, where he’ll receive an MRI on his right forearm, tweets MLB.com’s Jeffrey Flanagan. Via Flanagan (link), Young says that he’s felt some soreness in his forearm since Spring Training ended. However, he adds that the club’s medical staff has informed him that the “serious stuff checks out OK,” though it remains to be seen what the MRI will reveal. Young’s fastball velocity is actually up from previous seasons, but the increased zip hasn’t done him any favors; the 6’10” righty has been roughed up to the tune of a 6.68 ERA in 32 1/3 innings this season and has been astonishingly homer-prone, serving up 13 long balls in that time.
A couple more injury situations around the league that merit keeping an eye on…
- Diamondbacks outfielder David Peralta is meeting with hand specialist Dr. Don Sheridan in Phoenix on Thursday this week, he tell Nick Piecoro of the Arizona Republic (Twitter link). Peralta was hit by a pitch on the right wrist/forearm area last week and was out of Arizona’s lineup both Sunday and Monday, though he did pinch-hit in Sunday’s contest. He’s out of the lineup again tonight, Piecoro notes, and it seems reasonable to expect that he’ll be sidelined at least until he meets with Sheridan later this week. The 28-year-old indy league reclamation has been a revelation with the D-backs since first working his way onto the big league club in 2014, hitting a combined .295/.347/.485 in 999 plate appearances. This season, he’s batting .260/.321/.439 with three homers.
- Athletics first baseman/outfielder Mark Canha is heading back to the Bay Area tomorrow and will undergo an MRI on his left hip, reports Susan Slusser of the San Francisco Chronicle. Canha says he feels fine when running, but hitting is currently “excruciating,” adding that he can’t get any rotation in his hips and as such cannot swing very hard at the moment. “You don’t want to hope for something bad like a labrum tear to come up but at the same time, I want an answer about what’s wrong so we can pinpoint the problem,” said the 27-year-old. Canha has gotten off to a dreadful start to the season, hitting .122/.140/.341 in 44 plate appearances , though the hip troubles certainly help to explain the downturn in his productivity. He was placed on the disabled list today.
- MLB.com’s Jane Lee writes that right-hander Liam Hendriks, also placed on the DL by the Athletics today, will receive an MRI on his right elbow as well. Hendriks explained that he’s having difficulty getting full extension on his arm and has periodically experienced pain in the elbow since undergoing surgery to remove bone chips a few years ago.
Padres Claim Keith Hessler From Diamondbacks
5:40pm: Dennis Lin of the San Diego Union-Tribune tweets that Hessler will report to the Padres tomorrow and serve as the club’s 26th man for Wednesday’s double-header.
4:03pm: The Padres announced today that they have claimed left-hander Keith Hessler off waivers from the Diamondbacks. Arizona had designated Hessler for assignment back on April 30 in order to clear room on the roster for lefty Zac Curtis, whose contract was selected from Triple-A.
The 27-year-old Hessler has appeared in 20 games for the D-backs over the past two seasons but struggled, yielding 14 earned runs in 15 1/3 innings. He’s struggled in similarly limited exposure to the Triple-A level as well (5.32 ERA in 22 innings), but overall he enjoyed a strong season in the minors last year, working to a combined 2.14 ERA with 9.9 K/9 against 2.3 BB/9 across three levels. Lefties batted just .195/.246/.322 against Hessler between the Majors and Minors in 2015.
Angels Acquire Brendan Ryan
The Angels announced today that they have acquired shortstop Brendan Ryan from the Nationals in exchange for cash considerations or a player to be named later. He’ll join the Angels tonight and give them a defense-oriented replacement for the injured Andrelton Simmons, who requires surgery to repair a torn ligament in his thumb and is slated to miss the next six to eight weeks. Right-hander Garrett Richards, who is set to undergo Tommy John surgery, was moved to the 60-day DL to make room for Ryan on the 40-man roster.
Ryan, 34, has spent most of the past three seasons with the Yankees, hitting a combined .201/.244/.271 in a limited sample of 289 plate appearances. (Notably, the trade reunites him with former Yankees assistant GM Billy Eppler, who is now the GM for the Halos.) Ryan has never been much of a threat with the bat, but like Simmons, he’s a very highly regarded defender at shortstop and should at the very least provide the Halos with quality glovework during Simmons’ prolonged absence. Ryan began the season with the Nationals’ Triple-A affiliate, where he was batting .263/.305/.382 with one home run in 83 trips to the plate.
This past offseason, Ryan exercised a $1MM player option with the Yankees but found himself included with Adam Warren in the trade that sent Starlin Castro from the Cubs to the Yankees. Chicago would ultimately release Ryan, who inked a minors pact with the Nationals and (as MASNsports.com’s Mark Zuckerman tweets) nearly made the Major League roster with a fine spring showing. Ryan is a career .234/.295/.315 hitter in 2872 Major League plate appearances with the Cardinals, Mariners and Yankees. He’s logged nearly 5700 innings at shortstop in the Majors and drawn a +99 mark from Defensive Runs Saved. Ultimate Zone Rating, meanwhile, pegs Ryan at +11 runs per 150 games played.
MLB.com’s Alden Gonzalez first reported that the Angels had acquired Ryan (Twitter link).
Royals’ Raul Mondesi Jr. Receives 50-Game PED Suspension
3:57pm: Quinn points out (links to Twitter) that Mondesi Jr. is the first player to receive a reduced suspension — a possibility that was added to the latest drug agreement. Had he tested positive for a stronger substance, the reduction wouldn’t have been possible, but Clenbuterol is specifically listed among the substances for which a substance can be reduced if lack of intent can be proven.
Meanwhile, MLB.com’s Jesse Sanchez reports that as part of the reduced punishment, Mondesi Jr. will still be eligible for the postseason (Twitter link).
3:45pm: Royals top prospect Raul Mondesi Jr. has received a 50-game suspension after testing positive for the banned substance Clenbuterol, the league announced today. The son of the former big league outfielder of the same name, Mondesi saw his suspension dropped from 80 games to 50 games after the league and the MLBPA showed that the substance was present in a cold medication which Mondesi had taken, tweets Joel Sherman of the New York Post. Royals GM Dayton Moore said in a statement today that the team believes that Mondesi did indeed unknowingly take the substance:
“This is an unfortunate incident that we believe to be an innocent mistake, but these are the consequences that players face when they do not adhere to the policies that have been collectively bargained. We have a protocol in place with our medical team should a player ever have questions about what they may be taking, even if an over-the-counter medication. In this particular case, the protocol was not followed and the consequences are such. We remain supportive of Raul Mondesi Jr.”
Mondesi Jr. himself has also commented on the punishment, via press release:
“Today I agreed to accept a 50 game suspension from Major League Baseball. It is by far one of the hardest moments I have had to face in my life, but it is a decision that I accept and one that I take full responsibility for as a professional. I took an over-the-counter medication (Subrox-C) which I bought in the Dominican Republic to treat cold and flu symptoms. I failed to read the labeling on the medication or consult with my trainer or team about taking it and did not know it contained a banned substance. … I apologize to my organization, my teammates, the fans and everyone who has supported me in my career. Never did I intend to take a substance that would give me an unfair advantage on the field. It is solely my mistake and there are no excuses for my carelessness in not being fully informed of what I put in my body.”
Mondesi Jr., 20, rated as the game’s No. 29 prospect entering the season, according to Baseball America. He also rated 33rd on MLB.com’s Top 100, 73rd on the Top 100 of ESPN’s Keith Law and 16th on the Top 101 of Baseball Prospectus. The toolsy shortstop began the season at Double-A — his second stint at the level — and was hitting .250/.304/.462 with five homers and 11 steals through his first 113 plate appearances. Mondesi, of course, famously made his Major League debut for the Royals not only in the playoffs last season, but in the World Series against the Mets (he was 0-for-1 with a strikeout). While he’s likely a ways from an everyday role with the Royals’ big league club, he’ll miss out on 50 days of developmental time as a result of the punishment. His presence on Kansas City’s 40-man roster means that the team will also free up a 40-man spot during Mondesi Jr.’s time on the restricted list.
Recent reports from ESPN’s T.J. Quinn indicated that further PED suspensions would be on the horizon following the 80-game suspensions dished out to Miami’s Dee Gordon, Toronto’s Chris Colabello and Philadelphia’s Daniel Stumpf. Mondesi Jr. isn’t necessarily a household name, but Quinn stated at the time that it’s unlikely any significant names would be involved.
Devin Mesoraco Undergoes Shoulder Surgery
MAY 10: Surgery revealed more significant damage than had been anticipated, manager Bryan Price told C. Trent Rosecrans of the Cincinnati Enquirer (Twitter link). Expectations now are that Mesoraco will require a six-month recovery timeline.
MAY 6, 2:54pm: Mesoraco says he expects to be out for a minimum of four months, which essentially means he’l be down for the rest of the year, C. Trent Rosecrans of the Cincinnati Enquirer reports on Twitter.
2:36pm: The Reds announced this afternoon that catcher Devin Mesoraco, who was placed on the DL earlier this week, will undergo surgery next Tuesday to repair a torn labrum in his left shoulder (Twitter link). While Cincinnati did not give a definitive timeline for Mesoraco’s recovery, there would seem to be a chance that the injury ends up costing him the remainder of the season. Pablo Sandoval, for instance, underwent the same procedure just last week and has been announced as out for the duration of the season.
This marks the second consecutive season in which Mesoraco will lose most of the year to an injury that ultimately requires surgery. Last year it was a balky hip that ultimately needed surgical repair. The Reds briefly experimented with using Mesoraco in the outfield before conceding to the surgery, but that didn’t last long, and he was ultimately limited 23 games and 51 plate appearances. The 2016 campaign will be even more brief for Mesoraco, who has appeared in just 16 contests this season and collected just 43 plate appearances.
Suffice it to say, this isn’t what the Reds had in mind when signing Mesoraco to a four-year, $28MM contract on the heels of a 2014 breakout, though there weren’t any signs that he’d suffer through a breakdown of this magnitude. Mesoraco hit .273/.359/.534 with 25 home runs in that breakout ’14 season, and as a former first-round pick and widely regarded Top 100 prospect in his age-26 season, it seemed like he’d finally tapped into the potential scouts always saw in him. Now, he’ll hope to once again work his way back to health and give the Reds a healthy, productive season in 2017. Mesoraco earned $2.4MM last season and is earning $4.9MM in 2016. He’ll take home another $7.2MM next season and $13MM in 2018 before hitting the open market as a free agent.
MLBTR Chat Transcript
Click here to read a transcript of today’s chat with MLBTR’s Steve Adams.
Diamondbacks Sign Michael Bourn
The Diamondbacks have signed center fielder Michael Bourn to a minor league deal, per a club announcement. He’ll be assigned to Double-A to start with Arizona.
Bourn, 33, was cut loose by the Blue Jays over the weekend after previously receiving his release from the Braves. The veteran will only cost his new team a pro-rated portion of the league minimum salary, as the final year of his free agent contract with the Indians remains on Atlanta’s payroll.
It’s been quite some time since Bourn was a productive regular, but the D-Backs will hope there’s still a renaissance left. Arizona has struggled to fill in for injured star A.J. Pollock, who left a massive void in center field and isn’t expected back any time soon.
At his best, Bourn was a major threat on the bases, excellent defender, and good-enough hitter who conveyed plenty of overall value. But he’s mostly been injured and/or ineffective since going to Cleveland after a strong 2012 walk year.
Bourn will still need to earn another major league opportunity, and has to climb the ladder a bit after playing only at the High-A level in the Toronto organization. In his 41 plate appearances there, he put up a solid but hardly exciting .257/.366/.371 batting line and swiped one base in a single attempt.